Bone Marrow Aspirate Concentrates Market: Size, Share, Trends & Forecast (2024-2029)
The market report provided a comprehensive analysis segmented by Product (Systems, Accessories); by Application (Orthopedic Surgery, Wound Healing, Blood Cancer, Pain Management); by Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa).
Outlook
- The bone marrow aspirate concentrates market is estimated to be at USD 183.79 Mn in 2024 and is anticipated to reach USD 243.32 Mn in 2029.
- The bone marrow aspirate concentrates market is registering a CAGR of 5.77% during the forecast period of 2024-2029.
- Bone marrow aspirate concentrates (BMAC) are increasingly used in regenerative medicine, particularly in orthopedics and sports medicine. BMAC is gaining traction as a treatment for bone defects, cartilage repair, and musculoskeletal injuries and is widely adopted by orthopedic surgeons, especially in treating conditions like osteoarthritis and tendon injuries.
Request a free sample.
Ecosystem
- The participants in the global bone marrow aspirate concentrates industry dominate the market by providing innovative devices and solutions for BMAC extraction and concentration.
- These companies primarily focus on developing faster and more efficient BMAC preparation systems, along with partnerships between hospitals and biotech firms, fostering the advancement of BMAC technologies.
- Several important entities in the bone marrow aspirate concentrates market include Arthrex, Inc.; Aspire Medical Innovation GmbH; Globus Medical, Inc.; Scopio Labs Ltd.; Stryker Corp.; and others.
Ask for customization.
Findings
| Attributes | Values |
|---|---|
| Historical Period | 2018-2022 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Market Size (2024) | USD 183.79 Mn |
| Market Size (2029) | USD 243.32 Mn |
| Growth Rate | 5.77% CAGR from 2024 to 2029 |
| Key Segments | Product (Systems, Accessories); Application (Orthopedic Surgery, Wound Healing, Blood Cancer, Pain Management); Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa) |
| Key Vendors | Arthrex, Inc.; Aspire Medical Innovation GmbH; Globus Medical, Inc.; Scopio Labs Ltd.; Stryker Corp. |
| Key Countries | The US; Canada; Brazil; Argentina; China; India; Japan; South Korea; The UK; Germany; Italy; France; Russia; Turkey; Saudi Arabia |
| Largest Market | North America |
Get a free quote.
Trends
- Advancements in Point-of-Care Technology: There is a growing interest in developing more accessible and efficient point-of-care technologies for BMAC preparation. EmCyte Corporation, in 2023, launched a new system focused on enhancing procedural speed in outpatient facilities.
- Adoption of Digital Health Platforms: The integration of digital health platforms to monitor patient progress post-BMAC treatment is becoming a trend. These platforms allow for real-time monitoring and personalized follow-ups, which enhance patient care. In 2023, the Cleveland Clinic introduced a digital platform for tracking patient recovery following regenerative therapies.
- Personalized Medicine Approach: The personalized medicine approach is influencing the BMAC market as treatments are tailored to individual patients based on their unique cellular characteristics. In 2023, Stanford Medicine announced new protocols that incorporate personalized BMAC therapies for degenerative joint disease.
Speak to analyst.
Catalysts
- Popularity of Stem Cell Therapy: The increasing popularity of stem cell therapy in regenerative medicine is propelling the BMAC market. In 2023, the Regenerative Medicine Institute expanded its BMAC offerings, driven by growing patient demand for stem cell-based treatments for musculoskeletal conditions.
- Favorable Regulatory Environment: Regulatory bodies are supporting the use of BMAC by easing regulations on autologous cell therapies. In 2023, the FDA provided updated guidelines allowing faster approval for BMAC applications in orthopedics, which is encouraging market growth.
- Rising Sports-Related Injury: The increasing number of sports-related injuries, particularly among athletes and active individuals, is driving the demand for regenerative therapies like BMAC. In 2023, Sports Medicine Australia noted a 15% increase in BMAC procedures for treating ligament and tendon injuries in athletes.
Inquire before buying.
Restraints
- High Cost of BMAC Procedures: The cost of bone marrow aspirate concentrate (BMAC) procedures is a significant barrier to their widespread adoption. This high cost is primarily due to the advanced technology and specialized equipment required for extracting and processing bone marrow cells, as well as the expertise needed to administer the treatment.
- Ethical Concerns: Despite its autologous nature, ethical concerns persist regarding the use of stem cells in regenerative medicine. In 2023, the Hastings Center raised concerns about patient consent and the commercialization of unproven BMAC therapies, calling for stricter oversight.
- Lack of Standardized Protocols: The lack of standardized protocols for BMAC preparation and application creates inconsistencies in clinical outcomes. In 2023, Cedars-Sinai Medical Center highlighted the need for universal standards, noting variations in cell concentration and clinical effectiveness across different providers.
Personalize this research.
Hotspot
Explore purchase options.
Table of Contents
| 1. Introduction 1.1. Research Methodology 1.2. Scope of the Study 2. Market Overview / Executive Summary 2.1. Global Bone Marrow Aspirate Concentrates Market (2018 – 2022) 2.2. Global Bone Marrow Aspirate Concentrates Market (2023 – 2029) 3. Market Segmentation 3.1. Global Bone Marrow Aspirate Concentrates Market by Product 3.1.1. Systems 3.1.2. Accessories 3.2. Global Bone Marrow Aspirate Concentrates Market by Application 3.2.1. Orthopedic Surgery 3.2.2. Wound Healing 3.2.3. Blood Cancer 3.2.4. Pain Management 4. Regional Segmentation 4.1. North America 4.1.1. The US 4.1.2. Canada 4.1.3. Mexico 4.2. South America 4.2.1. Brazil 4.2.2. Argentina 4.2.3. Colombia 4.2.4. Chile 4.2.5. Rest of South America 4.3. Asia Pacific 4.3.1. China 4.3.2. India 4.3.3. Japan 4.3.4. South Korea 4.3.5. Rest of Asia Pacific 4.4. Europe 4.4.1. The UK 4.4.2. Germany 4.4.3. Italy 4.4.4. France 4.4.5. Spain 4.4.6. Rest of Europe 4.5. The Middle East 4.5.1. Turkey 4.5.2. UAE 4.5.3. Saudi Arabia 4.5.4. Rest of the Middle East 4.6. Africa 4.6.1. Egypt 4.6.2. South Africa 4.6.3. Rest of Africa 5. Value Chain Analysis of the Global Bone Marrow Aspirate Concentrates Market 6. Porter Five Forces Analysis 6.1. Threats of New Entrants 6.2. Threats of Substitutes 6.3. Bargaining Power of Buyers 6.4. Bargaining Power of Suppliers 6.5. Competition in the Industry 7. Trends, Drivers and Challenges Analysis 7.1. Market Trends 7.1.1. Market Trend 1 7.1.2. Market Trend 2 7.1.3. Market Trend 3 7.2. Market Drivers 7.2.1. Market Driver 1 7.2.2. Market Driver 2 7.2.3. Market Driver 3 7.3. Market Challenges 7.3.1. Market Challenge 1 7.3.2. Market Challenge 2 7.3.3. Market Challenge 3 8. Opportunities Analysis 8.1. Market Opportunity 1 8.2. Market Opportunity 2 8.3. Market Opportunity 3 9. Competitive Landscape 9.1. Arthrex, Inc. 9.2. Aspire Medical Innovation GmbH 9.3. Globus Medical, Inc. 9.4. Scopio Labs Ltd. 9.5. Stryker Corp. 9.6. Company 6 9.7. Company 7 9.8. Company 8 9.9. Company 9 9.10. Company 10 |
Know the research methodology.
Bone Marrow Aspirate Concentrates Market – FAQs
1. What is the current size of the bone marrow aspirate concentrates market?
Ans. In 2024, the bone marrow aspirate concentrates market size is $183.79 Mn.
2. Who are the major vendors in the bone marrow aspirate concentrates market?
Ans. The major vendors in the bone marrow aspirate concentrates market are Arthrex, Inc.; Aspire Medical Innovation GmbH; Globus Medical, Inc.; Scopio Labs Ltd.; Stryker Corp.
3. Which segments are covered under the bone marrow aspirate concentrates market segments analysis?
Ans. The bone marrow aspirate concentrates market report offers in-depth insights into Product, Application, and Geography.